Observational study / 2015
High coffee intake was linked observationally to lower risk of obesity and type 2 diabetes, but genetic analyses did not support a causal link.
Researchers analyzed 93,179 individuals from two general population cohorts and up to 78,021 additional individuals to assess observational and genetic relationships between coffee intake and metabolic outcomes. Observationally, high coffee intake was associated with a lower risk of obesity, metabolic syndrome, and type 2 diabetes. However, genetically derived high coffee intake (via variants near CYP1A1, CYP1A2, and AHR) was not convincingly associated with obesity, metabolic syndrome, type 2 diabetes, or related metabolic markers. Per-allele meta-analyzed odds ratios for type 2 diabetes ranged from 0.98 to 1.01 across the evaluated variants.
Shows an association, not proof of cause and effect.
- Study type
- Mendelian randomization and observational cohort study
- Who was studied
- 93,179 individuals from two cohorts, plus up to 78,021 individuals from DIAGRAM
- What was measured
- Risk of obesity, metabolic syndrome, type 2 diabetes, and related metabolic traits
THE PAPER
Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study.
Nordestgaard AT, Thomsen M, Nordestgaard BG. Int J Epidemiol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.